Brief: Essa Pharma Reports Q3 Loss Per Share Of $0.21
16/08/2021 12:33
Aug 16 (Reuters) - ESSA Pharma Inc EPIX.O :
* ESSA PHARMA PROVIDES CORPORATE UPDATE AND REPORTS
FINANCIAL
RESULTS FOR FISCAL THIRD QUARTER ENDED JUNE 30, 2021
* Q3 LOSS PER SHARE $0.21
* Q3 EARNINGS PER SHARE ESTIMATE $-0.26 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nCNWSCNLKa
Further company coverage: EPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ESSA Pharma
See all newsBrief: Essa Securityholders Approve Acquisition By Xenotherapeutics
Brief: Essa Securityholders Approve Acquisition By Xenotherapeutics
Brief: ESSA Pharma Provides Update On Its Application To The Supreme Court Of British Columbia For Amended Interim Order
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics
Brief: ESSA Pharma Amends Agreement with XenoTherapeutics